Clinical Study Results

What medical problems did participants have during the study?

This section is a summary of the medical problems the participants had during the study that the study doctors thought might be related to the study drug. These medical problems are called "adverse reactions". An adverse reaction is considered "serious" when it is life-threatening, causes lasting problems, or requires hospital care.

These adverse reactions may or may not be caused by the study drug. A lot of research is needed to know whether a drug causes an adverse reaction.

The websites listed at the end of this summary may have other information about adverse reactions or other medical problems that happened during this study.

How many participants had serious adverse reactions?

There were 5.5% of participants who had serious adverse reactions during the study. This was 20 out of 362 participants.

- 3.3% of participants who got anifrolumab had serious adverse reactions during the study. This was 6 out of 180 participants.

- 7.7% of participants who got the placebo had serious adverse reactions during the study. This was 14 out of 182 participants.

There was 1 participant in the anifrolumab group who died due to a serious adverse reaction during the study. This was due to pneumonia.